NAD+observational2020

Observing 3-hydroxyanthranilate-3,4-dioxygenase in action through a crystalline lens.

Proceedings of the National Academy of Sciences of the United States of America

confidence

Key findings

Structural and kinetic study of 3-hydroxyanthranilate-3,4-dioxygenase in crystallo; seven catalytic intermediates resolved, revealing O-atom transfer mechanism for quinolinic acid production.

View source on PubMed (PMID 32732435) ↗

Sample size
Not reported
Population
In vitro (crystalline enzyme study)
Dosing
Not reported
Duration
Not reported
Route
Not reported
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

The synthesis of quinolinic acid from tryptophan is a critical step in the de novo biosynthesis of nicotinamide adenine dinucleotide (NAD+) in mammals. Herein, the nonheme iron-based 3-hydroxyanthranilate-3,4-dioxygenase responsible for quinolinic acid production was studied by performing time-resolved in crystallo reactions monitored by UV-vis microspectroscopy, electron paramagnetic resonance (EPR) spectroscopy, and X-ray crystallography. Seven catalytic intermediates were kinetically and structurally resolved in the crystalline state, and each accompanies protein conformational changes at the active site. Among them, a monooxygenated, seven-membered lactone intermediate as a monodentate ligand of the iron center at 1.59-Å resolution was captured, which presumably corresponds to a substrate-based radical species observed by EPR using a slurry of small-sized single crystals. Other structural snapshots determined at around 2.0-Å resolution include monodentate and subsequently bidentate coordinated substrate, superoxo, alkylperoxo, and two metal-bound enol tautomers of the unstable dioxygenase product. These results reveal a detailed stepwise O-atom transfer dioxygenase mechanism along with potential isomerization activity that fine-tunes product profiling and affects the production of quinolinic acid at a junction of the metabolic pathway.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.